Jazz Pharmaceuticals (JAZZ) Tops Q4 Views; Guides FY11 Above Street

March 7, 2011 4:03 PM

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q4 EPS of $0.63, $0.03 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found